Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001013762-14-001204
Filing Date
2014-10-09
Accepted
2014-10-09 12:32:06
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT f10k2013a1_intellicellbio.htm 10-K/A 1528909
2 EXHIBIT 31.1 ex311.htm EX-31.1 10110
3 EXHIBIT 31.2 ex312.htm EX-31.2 10622
4 EXHIBIT 32.1 ex321.htm EX-32.1 5446
5 EXHIBIT 32.2 ex322.htm EX-32.2 4833
6 GRAPHIC image_001.jpg GRAPHIC 76811
  Complete submission text file 0001013762-14-001204.txt   7346582

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE svfc-20131231.xml EX-101.INS 946341
8 XBRL SCHEMA FILE svfc-20131231.xsd EX-101.SCH 75670
9 XBRL CALCULATION FILE svfc-20131231_cal.xml EX-101.CAL 59553
10 XBRL DEFINITION FILE svfc-20131231_def.xml EX-101.DEF 198208
11 XBRL LABEL FILE svfc-20131231_lab.xml EX-101.LAB 429323
12 XBRL PRESENTATION FILE svfc-20131231_pre.xml EX-101.PRE 316997
Mailing Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021
Business Address 30 EAST 76TH STREET, 6TH FLOOR NEW YORK NY 10021 (212) 249-3050
Intellicell Biosciences, Inc. (Filer) CIK: 0001125280 (see all company filings)

EIN.: 911966948 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-54729 | Film No.: 141149695
SIC: 2836 Biological Products, (No Diagnostic Substances)